Beta blockade in the primary prevention of hypertensive cardiovascular events with focus on sudden cardiac death

Norman M Kaplan

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Beta-adrenergic blocking agents are useful drugs in the treatment of hypertension. In multiple clinical trials, β blockers have been found to decrease the incidence of stroke and overall cardiovascular mortality. To provide maximal benefit, in particular, to blunt the early-morning surge in blood pressure associated with the increased circadian incidence of sudden cardiac death, the more cardioselective and longer-acting agents of this drug class are preferred.

Original languageEnglish (US)
JournalAmerican Journal of Cardiology
Volume80
Issue number9 B
StatePublished - Nov 13 1997

Fingerprint

Sudden Cardiac Death
Primary Prevention
Adrenergic beta-Antagonists
Incidence
Pharmaceutical Preparations
Myocardial Infarction
Clinical Trials
Blood Pressure
Hypertension
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Beta blockade in the primary prevention of hypertensive cardiovascular events with focus on sudden cardiac death. / Kaplan, Norman M.

In: American Journal of Cardiology, Vol. 80, No. 9 B, 13.11.1997.

Research output: Contribution to journalArticle

@article{e26707ae194b4fd2b601298e0dfa8ca2,
title = "Beta blockade in the primary prevention of hypertensive cardiovascular events with focus on sudden cardiac death",
abstract = "Beta-adrenergic blocking agents are useful drugs in the treatment of hypertension. In multiple clinical trials, β blockers have been found to decrease the incidence of stroke and overall cardiovascular mortality. To provide maximal benefit, in particular, to blunt the early-morning surge in blood pressure associated with the increased circadian incidence of sudden cardiac death, the more cardioselective and longer-acting agents of this drug class are preferred.",
author = "Kaplan, {Norman M}",
year = "1997",
month = "11",
day = "13",
language = "English (US)",
volume = "80",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "9 B",

}

TY - JOUR

T1 - Beta blockade in the primary prevention of hypertensive cardiovascular events with focus on sudden cardiac death

AU - Kaplan, Norman M

PY - 1997/11/13

Y1 - 1997/11/13

N2 - Beta-adrenergic blocking agents are useful drugs in the treatment of hypertension. In multiple clinical trials, β blockers have been found to decrease the incidence of stroke and overall cardiovascular mortality. To provide maximal benefit, in particular, to blunt the early-morning surge in blood pressure associated with the increased circadian incidence of sudden cardiac death, the more cardioselective and longer-acting agents of this drug class are preferred.

AB - Beta-adrenergic blocking agents are useful drugs in the treatment of hypertension. In multiple clinical trials, β blockers have been found to decrease the incidence of stroke and overall cardiovascular mortality. To provide maximal benefit, in particular, to blunt the early-morning surge in blood pressure associated with the increased circadian incidence of sudden cardiac death, the more cardioselective and longer-acting agents of this drug class are preferred.

UR - http://www.scopus.com/inward/record.url?scp=0030667974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030667974&partnerID=8YFLogxK

M3 - Article

C2 - 9375945

AN - SCOPUS:0030667974

VL - 80

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 9 B

ER -